CICON22 in New York: we are there!

Margaux Saillard is representing our lab at CICON22, visit her poster B014 on Friday! Get in touch with her to know the latest about TCR-engineered CD4 T cells for ACT.

http://www.cancerimmunotherapyconference.org/